Viewing Study NCT00193557


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-01 @ 9:40 PM
Study NCT ID: NCT00193557
Status: COMPLETED
Last Update Posted: 2010-06-29
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma
Sponsor: SCRI Development Innovations, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module